Intrinsic Value of S&P & Nasdaq Contact Us

Standard BioTools Inc. LAB NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
51/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.25
+232.5%

Stock Statistics — LAB

Standard BioTools Inc. (LAB) has a market capitalization of $381.29M and trades at $0.98. The 52-week range is 0.88-1.72.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.9, Earnings Per Share (EPS) of $-0.20, annual revenue of $85.33M.

The stock has a beta of 1.42, operates in the Healthcare sector.

Trading Data
Current Price$0.98
52-Week Range0.88-1.72
Volume6.1M
Avg Volume (30D)2.09M
Market Cap$381.29M
Beta (1Y)1.42
Company
IPO Date2011-02-10
Employees814
CEOMichael Egholm
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS34385P1084
CUSIP34385P108
Income (Latest Year)
Revenue$85.33M
Gross Profit$42.54M
EBITDA$-94.96M
Operating Income$-93.31M
Net Income$-74.9M
EPS$-0.20
EPS Diluted$-0.20
Shares Outstanding$381.62M
Balance Sheet (Latest Year)
Total Assets$567.75M
Current Assets$454.26M
Cash & ST Investments$187.58M
Total Liabilities$143.46M
Total Debt$30.83M
Net Debt$-87.39M
Total Equity$424.29M
Debt / Equity0.07
Valuation Ratios
P/E Ratio-4.9
P/S Ratio4.47
P/B Ratio0.9
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message